Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeuticsMedia Outreach|28/05/2024oleh RRINEWSSPartnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs